Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Rating)’s share price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $1.11 and traded as low as $0.83. Arcadia Biosciences shares last traded at $0.84, with a volume of 165,742 shares traded.
Wall Street Analysts Forecast Growth
Several research firms have weighed in on RKDA. Lake Street Capital lowered their target price on shares of Arcadia Biosciences from $4.50 to $3.50 in a research note on Thursday, March 31st. StockNews.com upgraded shares of Arcadia Biosciences to a “sell” rating in a research note on Tuesday, May 24th. Finally, HC Wainwright decreased their target price on Arcadia Biosciences from $6.00 to $4.00 in a research note on Monday, April 25th.
Arcadia Biosciences Stock Performance
The stock has a 50 day moving average of $1.11 and a 200 day moving average of $1.15. The stock has a market capitalization of $18.66 million, a P/E ratio of -0.88 and a beta of 0.07.
Institutional Investors Weigh In On Arcadia Biosciences
Several large investors have recently made changes to their positions in RKDA. State Street Corp grew its holdings in Arcadia Biosciences by 76.7% in the 1st quarter. State Street Corp now owns 99,300 shares of the basic materials company’s stock worth $139,000 after buying an additional 43,100 shares in the last quarter. MYDA Advisors LLC boosted its position in Arcadia Biosciences by 66.7% during the 4th quarter. MYDA Advisors LLC now owns 100,000 shares of the basic materials company’s stock worth $104,000 after acquiring an additional 40,000 shares during the period. Finally, Jane Street Group LLC grew its stake in shares of Arcadia Biosciences by 215.8% in the first quarter. Jane Street Group LLC now owns 36,458 shares of the basic materials company’s stock worth $51,000 after purchasing an additional 24,913 shares in the last quarter. Institutional investors and hedge funds own 10.55% of the company’s stock.
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications.
- Get a free copy of the StockNews.com research report on Arcadia Biosciences (RKDA)
- 3 Large Caps With Bullish Chart Patterns
- Medtronic Stock Keeps Ticking Forward
- Occidental Petroleum Leads Exxon Mobil, Chevron Ahead Of Next Week’s Earnings
- The Bull and Bear Case for Investing in AMD
- Simpson Manufacturing Quietly Builds Foundations For Growth
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.